Neurology

Helius Medical Technologies, Inc. Expands Stroke Trial at the Medical University of South Carolina

-- Number of subjects increased from 12 to 60 ---- Portable Neuromodulation Stimulator (PoNS®) will be used to evaluate cranial-nerve…

12 months ago

Voyager Therapeutics Announces Second Quarter 2023 Conference Call and Webcast

CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR) a biotechnology company dedicated to breaking through…

12 months ago

ABVC Signs Term Sheet to Acquire Real Estate Assets for Strategic Investments

FREMONT, CA, July 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical…

12 months ago

Kriya Announces $150 Million Addition to its Series C, Bringing Total Round to over $430 Million to Further its Mission of Delivering Gene Therapies for Prevalent Diseases

– Kriya's therapeutic pipeline addresses a broad range of diseases that collectively affect millions of patients worldwide—with a goal of…

12 months ago

AC Immune SA Appoints New Chief Medical Officer

AC Immune SA Appoints New Chief Medical Officer Nuno Mendonça, MD appointed new Chief Medical Officer and Executive Committee memberLausanne,…

12 months ago

BPGbio and VELL Health Collaborate to Launch Revolutionary Global Health Initiative to Improve Type 2 Diabetes Outcomes in Guyana

Partnership supports Guyana’s launch of their Wellness Initiative to promote a healthier lifestyle among its citizensBOSTON--(BUSINESS WIRE)--BPGbio, Inc., a leading…

12 months ago

Capricor Therapeutics Announces Appointment of Philip J. Gotwals, Ph.D. to its Board of Directors

SAN DIEGO, July 24, 2023 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of…

12 months ago

Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3

LAVAL, QC / ACCESSWIRE / July 13, 2023 / Bausch Health Companies Inc. (NYSE/TSX:BHC) will release its second-quarter financial results…

1 year ago

Psyence Group Corporate Update

Highlights: Drug development, Phase IIb clinical trial advanced planning underway in AustraliaPsyence granted worldwide licensing agreement to commercialize Filament’s PEX010…

1 year ago

Aerovate Therapeutics Appoints Habib Dable To Its Board of Directors

WALTHAM, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical-stage biopharmaceutical company focused on developing…

1 year ago